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Adenosine 5’-triphosphate (ATP), released at the leading edge of migrating neutrophils, 
amplifies chemotactic signals. The aim of our study was to investigate whether neutrophils 
express ATP-gated P2X1 ion channels and whether these channels could play a role in 
chemotaxis. Whole-cell patch clamp experiments showed rapidly desensitizing currents in 
both human and mouse neutrophils stimulated with P2X1 agonists, alpha,beta-methylene ATP 
(αβMeATP) and beta,gamma-methylene ATP (βγMeATP). These currents were strongly 
impaired or absent in neutrophils from P2X1-/- mice. In Boyden chamber assays, αβMeATP 
provoked chemokinesis and enhanced formylated peptide- and interleukin-8-induced 
chemotaxis of human neutrophils. This agonist similarly increased W-peptide-induced 
chemotaxis of wild-type mouse neutrophils while it had no effect on P2X1-/- neutrophils. In 
human as in mouse neutrophils, αβMeATP selectively activated the small RhoGTPase RhoA 
that caused reversible myosin light chain phosphorylation. Moreover, the αβMeATP-elicited 
neutrophil movements were prevented by the two Rho kinase inhibitors, Y27632 and H1152. 
In a gradient of W-peptide, P2X1-/- neutrophils migrated with reduced speed and displayed 
impaired trailing edge retraction. Finally, neutrophil recruitment in mouse peritoneum upon E. 
coli injection was enhanced in wild type mice treated with αβMeATP while it was 
significantly impaired in the P2X1-/- mice. Thus, activation of P2X1 ion channels by ATP 
promotes neutrophil chemotaxis, a process involving Rho kinase-dependent actomyosin-
mediated contraction at the cell rear. These ion channels may therefore play a significant role 





Neutrophils are key cells of the innate immune system that participate in a vast majority of 
inflammation-related diseases, such as coronary artery diseases, rheumatoid arthritis, and 
sepsis (1-3). They are programmed to exit the circulation and chemotax toward epicentres of 
inflammation, guided by gradients of a variety of inflammatory mediators (4). Neutrophils 
become polarized morphologically in response to chemotactic stimuli. These morphological 
changes are accompanied by a strongly polarized distribution of intracellular signal 
transduction components. 3’-phosphoinositol lipids (PI3Ps) and phosphoinositide-3’-kinases 
(PI3Ks), Rho GTPases, such as RhoA, Rac, and Cdc42, and the actin and microtubule 
cytoskeletons play key roles in signaling polarity. Attractant receptors, acting on different G 
proteins, trigger two divergent pathways that contribute to polarity (5). Frontness depends 
upon Gi-mediated production of PI3Ps, the activated form of Rac, and F-actin. G12 and G13 
trigger backness signals, including activation of Rho, a Rho-dependent kinase, and myosin II. 
Functional incompatibility causes the two resulting actin assemblies to aggregate into separate 
domains, making the leading edge more sensitive to attractant than the back (5).  
In addition, mechanisms of signal amplification have been proposed that contribute to 
maintain signaling polarity even in a shallow gradient. These mechanisms involve the release 
of ATP from neutrophil leading edge and its rapid metabolism to ADP, AMP and adenosine 
(6). As a neutrophil moves toward an attracting stimulus, a rapid and transient release of ATP 
further enforces its directional movement by autocrine signaling via P2Y2 and A3 receptors. 
In support of this, neutrophils lacking P2Y2 receptors showed a loss in gradient sensing, 
whereas cells without A3 receptors showed correct directionality but diminished speed (6). 
Although the intracellular mechanisms remain undefined, these findings demonstrate the 
importance of extracellular ATP in the control of neutrophil chemotaxis.  
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Because ATP is released by activated platelets and leukocytes, as a result of multiple stress 
stimuli, and upon cell lysis, its concentration can become elevated at sites of inflammation 
(7). By acting on neutrophils in a paracrine manner, ATP could thus help these cells to locate 
bacteria and tissue damage. We therefore wondered whether neutrophils expressed other ATP 
receptors that could contribute to chemotaxis. ATP acts on specific cell surface P2 receptors 
belonging to two subclasses, the G protein-coupled P2Y receptors and the ATP-gated P2X 
non-selective cation channels (8, 9). Eight human P2Y receptors, P2Y1, P2Y2, P2Y4, P2Y6, 
P2Y11-14, and seven P2X subtypes, P2X1-7, have been identified (9-11). Neutrophils express 
multiple P2X subtype mRNAs: P2X1,4,5,7 (6, 12-14). However, the presence of functional P2X 
ion channels in neutrophils has never been shown and their contribution to neutrophil 
migration has never been investigated. P2X ion channels are widely distributed in various cell 
types and tissues (15). Only P2X7 receptors are thus far established as having physiological 
roles in inflammation, mostly via a rapid activation of caspase-1 with subsequent release of 
the proinflammatory cytokine IL-1β from activated macrophages and microglia (15, 16). 
P2X7 is also an important modulator of T cell functions (17-20).  
In this study, we demonstrate that both human and mouse neutrophils express P2X1 ion 
channels that play a significant role in the neutrophil response to chemotactic stimuli. 
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Materials and Methods 
 
Reagents 
α,β-methylene ATP (αβMeATP), β,γ-Methylene ATP (βγMeATP), fMLP, BSA were from 
Sigma-Aldrich (Bornem, Belgium). W-peptide was from Innovagen (Lund, Sweden). Mouse 
type IV collagen was from BD Biosciences (Erembodegem, Belgium). Home-made 
polyclonal rabbit anti-P2X1 antibody was described previously.(21) Polyclonal goat anti-
myosin light chain (MLC)2 and anti-phospho MLC (Thr18/Ser19), mouse anti-RhoA, and 
mouse anti-Rac2 antibodies were from Santa-Cruz (Santa Cruz, CA). Mouse anti-Rac1 
(23A8) was from Upstate Biotechnology (Heule, Belgium). Mouse anti-Cdc42 was from BD 
Biosciences (Erembodegem, Belgium). AlexaFluor488-coupled phalloidin was from 
Invitrogen (Merelbeke, Belgium). 
 
Mice 
Animals used in this study were 8-12 week-old C57BL/6 mice (wild-type and P2X1-/- 
described previously (22)) that were housed in specific pathogen-free animal facilities. All 
experiments were carried out following the guidelines of and in agreement with the local ethic 
committee. 
 
Human neutrophil isolation 
Fresh acid-citrate-dextrose (ACD; 93 mM sodium citrate, 7 mM citric acid, 0.14 mM 
dextrose, pH 6.5)-anticoagulated peripheral blood was drawn by venipuncture from healthy 
volunteers. Institutional Review Board approval was obtained from the Centre Hospitalier 
Universitaire de Liège, and informed consent from volunteers was obtained in accordance 
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with the Declaration of Helsinki. Neutrophils were isolated by plasma/percoll gradient 
centrifugation mainly as previously described (23). 
 
Mouse peritoneal neutrophil isolation 
Mice were injected intraperitoneally with 500µl 4% thioglycollate in PBS. Three hours after 
injection, peritoneal lavage was performed with 5 ml ice-cold PBS. Neutrophils were isolated 
by positive magnetic selection using an anti-Gr1 antibody (Miltenyi Biotec, Utrecht, The 
Netherlands). Cells were counted and resuspended at a density of 1 X 106 cells/ml in HBSS 
containing 1 mM CaCl2, 2 mM MgCl2 and 0.2% BSA (referred as to HBSS buffer). 
 
Western blotting 
Western blotting detection of P2X1, phospho-MLC, and MLC proteins in neutrophil extracts 
was performed as previously described (24-26). For phospho-MLC, and MLC detection, 
neutrophils were treated with 2.7 mM diisopropyl fluorophosphate for 15 min prior to 
stimulation with agonist for indicated times. 
 
Rho GTPases pull-down assays 
After pretreatment with 2.7 mM diisopropyl fluorophosphate for 15 min, neutrophils were 
stimulated with αβMeATP for the indicated times. Reaction was stopped by lysing the cells 
in the following ice-cold buffer: 0.5% Triton X-100, 25 mM HEPES, pH 7.3, 150 mM NaCl, 
5mM MgCl2, 0.5mM EGTA, 5 mM DTT, 4% glycerol, containing Complete protease 
inhibitors, 10 mM sodium fluoride, 2 mM β-glycerophosphate, 2 mM sodium orthovanadate 
and 1 mM phenylmethylsulphonyl fluoride. Lysates were centrifuged for 8 min at 13,000g. 
An aliquot of each supernatant was denatured in Laemmli buffer to measure the total 
RhoGTPase content by Western blotting. For pull-down assays, supernatants were incubated 
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for 30 min with 30 µg of GST-PBD protein containing the Cdc42 and Rac binding region of 
PAK-1B, or GST-RBD protein containing the Rho binding region of rhotekin affinity linked 
to glutathione-Sepharose beads. The beads were washed four times in lysis buffer and boiled 




During isolation, both murine and human neutrophils were treated with 15U/ml apyrase 
(Grade I, Sigma-Aldrich) to remove extracellular ATP and prevent P2X1 desensitization. 
Isolated neutrophils were adhered on a tissue culture dish and placed in a perfusion chamber 
on an inverted microscope that was continuously perfused with external solution containing 
147 mM NaCl, 3 mM KCl, 2 mM CaCl2, 10 mM  HEPES, and 13 mM glucose (pH = 7.4 with 
NaOH). Whole cell patch clamp recordings were made at room temperature (23 ± 1°C) using 
an Axopatch-1D amplifier and pCLAMP8 software (Axon Instruments, Union City, CA). 
Pipette resistances ranged from 5 to 12 M  when filled with internal solution containing 147 
mM NaCl, 10 mM EGTA, and 10 mM HEPES (pH 7.3 with NaOH). Gigaseals were obtained 
and currents were sampled at 10KHz after low-pass filtering at 1KHz. Series resistance was 
not routinely compensated. The membrane potential was clamped at –70 mV throughout the 
experiments. Fast solution changes were achieved with the complete VC-6 fast-step perfusion 
system (Harvard apparatus) together with a multi-barrel glass pipette that was positioned 
about 50 µm from the cell during drug application. Analysis of data was achieved with 
Clampfit 8.0 (Axon Instruments, Union City, CA) and Prism 4.0 (Graphpad, Software Inc., 
San Diego, CA). 
 
Boyden Chamber assays 
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48-well microchemotaxis plates (Neuro Probe Inc., Gaithersburg, MD) and 8 µm (human 
neutrophils) or 5 µm (mouse neutrophils) pore-size polyvinylpyrrolidone-free polycarbonate 
membranes (VWR, Leuven, Belgium) were used. Chemoattractant diluted in HBSS buffer 
was placed in the chamber bottom wells, and neutrophil suspension (1 X 106 cells/ml) was 
added to the top wells. HBSS buffer was used as a negative control. The plate was incubated 
for 1 hour at 37°C. Membrane was removed, fixed and stained using a Diff-Quick stain set 
(Medion diagnostics, Düdingen, Switzerland). The number of neutrophils that migrated to the 
lower side of the membrane was counted in ten random microscope fields using the 40X 
objective (Olympus BHB, Aartselaar, Belgium). The chemotactic index is defined as follows: 
(mean neutrophils per field in chemoattractant – mean neutrophils per field in HBSS) / mean 
neutrophil per field in HBSS). 
 
F-actin staining and confocal microscopy 
Murine peritoneal neutrophils (1.106/ml in HBSS buffer) were let to adhere on collagen type 
IV-coated microslides (Ibidi, Integrated BioDiagnostics, Martiensried, Germany) for 15 
minutes at room temperature. Neutrophils were incubated with 100nM W-peptide for the 
indicated times, before fixation in 4% paraformaldehyde. Cells were incubated in HBSS 
containing 0.25% triton-X100, 2% BSA and AlexaFluor488-coupled phalloidin. Microslides 
were analyzed with a Leica TCS SP2 confocal microscope equipped with a 63x objective 
(Leica Microsystems Heidelberg GmbH). 
 
Time-lapse video microscopy: chemotaxis microslides 
Chemotaxis microslides coated with type IV collagen or fibronectin (Ibidi, Martiensried, 
Germany) were used to study two-dimensional neutrophil migration. Murine neutrophils (3 X 
106 cells/ml in HBSS buffer) were adhered to coated-microslides for 15 min at RT. Microslide 
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reservoirs were then filled with buffer, and chemoattractant was added. After 15 min, to allow 
diffusion of the chemoattractant and establishment of a linear gradient, neutrophil migration 
was observed using a Nikon Eclipse TS100 inverted microscope, equipped with a Nikon 
digital sight DS-2Mv camera. The Basic Research NIS-Elements Imaging software (Nikon) 
was used for time-lapse imaging. Phase contrast images were captured every minute. Cell-
tracking software (Chemotaxis and Migration Software tool based on ImageJ, Ibidi) was used 
to characterize chemotaxis from the captured images. The average circularity ratio of cells is a 
well-known compactness measure of a shape computed by ImageJ and defined as C = 4 π 
(area) / (perimeter)^2. For a perfect circle C equals 1 whereas for a long, thin shape, C tends 
to 0. This ratio was computed for each cell at each capture by successively applying the 
Canny edge detector using FeatureJ plugin, thresholding using the Isodata algorithm, and 
morphological operations (fill holes, erosion, and dilation). Parameter default values were 
used for all experiments. 
 
Static adhesion assay 
96-well culture plates were coated with mouse type IV collagen (40µg/ml). Neutrophils from 
wild-type or P2X1-/- mice were allowed to adhere to collagen for 15 min at 37°C. Unattached 
cells were gently removed and wells were rinsed once with HBSS buffer. Neutrophil adhesion 
was determined using the CellTiter-Glo luminescent cell viability assay (Promega, Leiden, 
The Netherlands). Luminescence was measured in a Victor2 multilabel microplate reader 
(Perkin Elmer). 
 
Mouse peritonitis model 
Wild-type mice (n=4-6 mice per group, 3 independent experiments) were intraperitoneally 
injected with 100 µl αβMeATP (0.16µmol/kg) or vehicle 15 min before intraperitoneal 
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injection of 150 µl of E. coli (ATCC 25922) (50 X 106 colony forming units/ml) or PBS. 
Mice were then injected with 100 µl αβMeATP after 1 and 2 hours. For experiments with 
P2X1-/- mice, animals were injected once with 150 µl of E. coli or PBS. After 3 hours, the 
mice were killed, and peritoneal exudate cells were harvested by 5 successive washes with 1 
ml PBS containing 0.5% BSA and 2 mM EDTA. Total amounts of peritoneal cells were 




Data are represented as mean ± SD of at least 3 independent experiments. Statistical analyses 
were performed using either Student’s t-test or, for multiple comparisons, one-way ANOVA 
followed by the Bonferroni’s test.  
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Results     
 
Human neutrophils express functional P2X1 channels.  
In agreement with previous studies (6, 13), real time RT-PCR analyses indicated that human 
peripheral neutrophils mainly expressed P2X1 subtype mRNAs (data not shown). Lower 
levels of P2X4, P2X5 and P2X6 mRNA subtypes were also detected. We assessed whether 
P2X1 proteins were expressed in neutrophil membranes and formed functional ion channels. 
Expression of P2X1 proteins was analyzed by Western blotting (Fig. 1A). The apparent 
molecular weight of neutrophil P2X1 proteins was about 60 kD, similar to that of the 
glycosylated form of platelet P2X1 (27). Functionality of the P2X1 ion channels was studied 
by whole-cell patch clamp analyses. Application of the P2X1 selective agonist αβMeATP (10 
µM) induced rapidly desensitizing inward currents of about 40 pA/pF (Fig. 1B). Currents of 
lower density (20 pA/pF) were observed upon application of the same concentration of the 
other P2X1 agonist, βγMeATP, which is consistent with P2X1 pharmacological properties 
described in other cell types (28, 29). Moreover, applying ATP (100 µM) gave rise to similar 
rapidly desensitizing currents (data not shown), suggesting that human neutrophils do not 
express functional P2X ion channels characterized by slow desensitization kinetics (composed 
of P2X4, P2X5 and/or P2X6 subunits). 
 
αβMeATP induces random migration and enhances chemotaxis of human peripheral 
neutrophils. 
The effect of αβMeATP on neutrophil chemotaxis was investigated using Boyden chamber 
assays (30) (Fig. 2A). We placed neutrophils into the chamber top wells and allowed them to 
migrate in the bottom wells. αβMeATP (10 µM), placed in the bottom wells, did not induce 
significant neutrophil chemotaxis. However, pretreating neutrophils with αβMeATP 
12 
 
significantly increased chemotactic index (CI). In the absence of αβMeATP in the bottom 
wells, the migratory activity of αβMeATP-treated neutrophils also tended to be augmented. 
Similar results were obtained when βγMeATP was used as P2X1 agonist (data not shown). 
Neutrophils chemotaxed efficiently in response to interleukin-8 (CI=10.5) (Fig. 2B). We 
found that pretreating the cells with αβMeATP markedly enhanced chemotaxis induced by 
IL-8 (CI=32.6) (Fig. 2B), at any tested IL-8 concentration (from 10 to 500 ng/ml) (data not 
shown). A similar phenomenon was observed when formylated peptide (fMLP, 100 nM) was 
used as chemoattractant (Fig. 2C). Only short treatment with the agonist (around 1 min) led to 
the increased chemotaxis (supplemental Fig. S1C).5 When longer pre-incubation periods were 
used (from 5 min), αβMeATP failed to enhance neutrophil migration, pointing to the 
importance of the kinetics of P2X1-mediated signaling. Thus, stimulation of neutrophils with 
P2X1 agonists promoted neutrophil chemotaxis in response to both endogenous (IL-8) and 
exogenous bacterial (fMLP) chemoattractant. The αβMeATP-induced increase of chemotaxis 
toward fMLP was fully inhibited by the selective P2X1 antagonist, NF449, and was similar to 
the effect of the nonhydrolyzable ATP analog adenosine 5’-O-(3-thiotriphosphate) (ATP-γ-S) 
(supplemental Fig. S1A,B).5 ATP was more potent to enhance migration than the two analogs, 
possibly because of ATP conversion to adenosine during cell migration (supplemental Fig. 
S1B).5 Strikingly, the addition of αβMeATP in the chemoattractant medium failed to increase 
chemotaxis (Fig. 2D). Taken together, these results indicated that αβMeATP was not 
chemotactic by itself but could induce random neutrophil migration (chemokinesis). This is in 
sharp contrast with the effect of the P2Y2 receptor agonist, UTP, that was able to increase 
fMLP-induced chemotaxis when added together with fMLP in the bottom wells of the Boyden 
chamber, as well as when it was placed in direct contact with the cells (Fig. 2E).  
 
αβMeATP-induced migration involves the Rho pathway 
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We then investigated the molecular mechanisms underlying the αβMeATP-induced 
migration. In order to analyze the activity of Rho GTPases, central players in signaling 
polarity during cell migration (4), we performed GST-pull down assays using lysates of 
αβMeATP-stimulated human neutrophils.   
We found that αβMeATP (10 µM) rapidly and selectively activated RhoA (Fig. 3). The 
amount of GTP-bound RhoA increased by 4.2 ± 0.4, 4.1 ± 1.4 and 3.7 ± 1.7 fold after 10 s, 30 
s, and 1 min of stimulation, respectively. In contrast, αβMeATP failed to activate Rac1, Rac2 
or Cdc42 (Fig. 3B). Consistently with the activation of the Rho pathway, we also found that 
αβMeATP increased myosin light chain (MLC) phosphorylation, being maximal after 1 min 
and disappearing after 5 min (Fig. 3C).  
To determine whether the Rho pathway was involved in αβMeATP-induced chemokinesis, 
neutrophils were incubated with two different inhibitors of the Rho kinase, Y27632 and 
H1152, and Boyden Chamber assays were performed. Both inhibitors fully blocked neutrophil 
migration induced by αβMeATP (Fig. 3D). Under our experimental conditions, Y27632 (5 
µM) alone failed to inhibit chemotaxis toward fMLP whereas it abolished the effect of 
αβMeATP (Fig. 3E). On the contrary, inhibiting PI3Kγ with AS252424 (31, 32) failed to 
modify αβMeATP-triggered chemokinesis (data not shown) whereas it totally blocked the 
fMLP-induced chemotaxis (data not shown). Taken together, these results indicate the 
involvement of the RhoA/Rho Kinase pathway in P2X1-mediated neutrophil chemokinesis.  
 
Characterization of P2X1-/- neutrophils 
To further characterize P2X1 function in neutrophil chemotaxis and to assess agonist 
specificity, we used cells isolated from P2X1-/- mice.(22) The hematological profile of these 
mice has been analyzed in a previous study, revealing normal erythrocyte and leukocyte 
counts, hemoglobin and hematocrit (33). The distribution of leukocyte cell types was also 
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similar between wild-type and knock-out mice. In transmission electron microscopy, we 
showed that P2X1-/- peripheral neutrophils had no apparent ultrastructural abnormalities (data 
not shown). We then performed whole-cell patch clamp experiments on mouse peritoneal 
neutrophils. As observed in human cells, neutrophils from wild-type mice displayed rapidly 
desensitizing inward currents upon stimulation with the two P2X1 agonists, αβMeATP (10 
µM) and βγMeATP (10 µM). Current density was 136.9 ± 44.9 pA/pF and 51.6 ± 22.1 pA/pF 
(means ± SEM), respectively (Fig. 4). βγMeATP-induced currents were absent in P2X1-/- 
neutrophils. A remaining rapidly desensitizing current could still be induced by αβMeATP in 
cells lacking P2X1 (mean current density = 70.7 ± 20.2 pA/pF). P2X1 characteristics 
(sensitivity to activation by αβMeATP and rapid desensitization kinetics) are shared by P2X3 
homomeric channels (28). While βγMeATP is reported to be equipotent to αβMeATP at 
P2X1, it is approximately 30-to 50-fold less potent at P2X3. Real time RT-PCR analyses 
indicated that, in contrast to human neutrophils, mouse neutrophils expressed P2X3 subtype 
mRNAs (data not shown). P2X3 channels might thus mediate the residual αβMeATP-induced 
current in P2X1-/- neutrophils. 
We then investigated the chemotactic properties of P2X1-/- neutrophils in vitro. We first used 
Boyden chamber assays to assess direction sensing (30). Migration toward the chemotactic 
peptide W-peptide was similar for both P2X1-/- and wild-type neutrophils (Fig. 5A), and about 
10 fold higher than toward the HBSS buffer control (data not shown). This indicated that 
P2X1 was not required for direction sensing. Nevertheless, pretreating wild-type neutrophils 
with αβMeATP (10 µM) significantly enhanced W-peptide-induced chemotaxis (Fig. 5A), as 
observed for human neutrophils. The migratory activity of P2X1-/- cells was not affected by 




As observed for human cells, P2X1-mediated neutrophil migration also involved the Rho 
pathway in murine neutrophils. In Boyden chamber assays, the enhancing effect of αβMeATP 
on W-peptide-induced migration of wild-type neutrophils was fully blocked when cells were 
pre-treated with inhibitors of the Rho Kinase (Figure 5B). Using GST-pull down assays, we 
found that P2X1 activation with αβMeATP was able to rapidly increase RhoA activity in 
wild-type neutrophils whereas RhoA activity in P2X1-/- neutrophils was not affected by this 
agonist (Figure 5C). 
 
Reduced speed and static adhesion for P2X1-/- neutrophils 
We next investigated two-dimensional chemotaxis of P2X1-/- neutrophils using Ibidi 
chemotaxis microslides and time-lapse video microscropy. Mouse peritoneal neutrophils were 
adhered on collagen type IV and placed in a gradient of W-peptide. Both wild-type and P2X1-/- 
neutrophils migrated toward the W-peptide gradient (supplemental videos 1 and 2)5. Cell 
tracking showed that the forward migration index determined for P2X1-/- neutrophils was 
comparable to the one of wild-type cells, indicating that neutrophils can orient normally in the 
absence of P2X1. Nevertheless, further analyses revealed diminished migration speed for 
P2X1-/- neutrophils (Fig. 6A). The addition of the ATP/ADP scavenger, apyrase, reduced the 
migration speed of wild-type neutrophils to a similar extent as for P2X1-/- cells, pointing to a 
contribution for ATP released by migrating cells during the assays (supplemental Fig. S2B).5 
A reduced migration speed was also observed when P2X1-/- neutrophils were adhered to 
fibronectin (supplemental Fig. S2A),5 indicating that this defect was not substrate-specific. 
Moreover, the detachment of fine trailing appendages at the rear of P2X1-/- neutrophils 
appeared to be delayed as compared to wild-type cells (Fig. 6B). Among 80 cells analyzed, 
75% of P2X1-/- neutrophils showed a tail persisting for 45 min whereas this percentage was 
16.7% for wild-type cells (46.7% of the wild-type cells displayed a tail persisting for 31 to 45 
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min, and 23.3% for 16 to 30 min). To support these observations, we quantified cell 
deformation during the time course of the experiments. For this purpose, we calculated 
circularity ratios for all cells (see Material and Methods). During migration of wild-type 
neutrophils, quite constant and repetitive oscillations of the averaged ratios occurred 
(representing cell deformation) but the cells always recovered their original shape (Fig. 6C). 
Notably, although such oscillations were also observed for P2X1-/- neutrophils, from about 35 
min of migration up to 60 min, the shape of these cells remained thinner and longer than at 
earlier time steps, possibly reflecting an impaired trailing edge retraction. Furthermore, static 
adhesion of P2X1-/- neutrophils to collagen IV was found to be reduced by about 30% (Fig. 
6D). Thus, activation of P2X1 by released ATP could promote cell movement during 
chemotaxis, facilitating cell deformation and adhesion dynamics. In agreement with the 
Boyden chamber assays, P2X1 would not contribute to cell orientation (gradient sensing). In 
order to determine whether P2X1 would be involved in actin cytoskeleton reorganization in 
migrating neutrophils, we performed F-actin staining in WT and P2X1-/- neutrophils uniformly 
stimulated with W-peptide. Polarized actin polymerization appeared to occur normally in cells 
lacking P2X1 (Fig. 7).  
 
P2X1 activation promotes neutrophil recruitment in vivo in a peritonitis model 
The role of P2X1 in neutrophil chemotaxis was further investigated in vivo by assessing cell 
recruitment in the peritoneal cavity of mice intraperitoneally injected with living E. coli 
bacteria. αβMeATP-treated mice showed significantly increased numbers of neutrophils in 
the peritoneum as compared to untreated animals (Fig. 8A), indicating that P2X1 activation 
promotes bacteria-induced neutrophil recruitment in vivo. Accordingly, we found that E.coli-
induced neutrophil recruitment was impaired in the P2X1-/- mice as compared to wild-type 





Our data demonstrate for the first time that human and mouse neutrophils express functional 
P2X1 ion channels. Whole-cell patch clamp revealed that two P2X1 agonists evoked rapidly 
desensitizing inward currents that were absent (βγMeATP) or impaired (αβMeATP) in 
neutrophils isolated from P2X1-/- mouse peritoneum.  
Our work significantly extends the knowledge on P2X1 expression in various blood cell types. 
In platelets, P2X1, strongly expressed as a heavily glycosylated protein (27), contributes to 
thrombus formation under high shear stress conditions and has been proposed to be an 
interesting new target for antithrombotic drugs (24, 33, 34). Previous studies of P2X1 receptor 
expression in other human hematopoietic cell types have reported P2X1 receptor mRNA in 
total human blood leukocytes (35). Expression of P2X1 receptor protein has also been found 
in a variety of leukemic human cell lines, including THP1 monocytes and dibutyryl cAMP-
differentiated HL-60 granulocytes (27), and P2X1 receptor function has been described in 
PMA-differentiated HL-60 myeloid cells (36). However, until now no P2X1 protein could be 
detected in circulating neutrophils and monocytes, so that P2X1 expression was thought to be 
repressed at the most distal stages of phagocyte differentiation (27). Our data and a recent 
study describing the expression of functional P2X1 ion channels in mouse peritoneal 
macrophages (37) question this hypothesis. 
We present evidence that P2X1 ion channels contribute to the control of neutrophil 
chemotaxis. Firstly, the selective P2X1 agonists, αβMeATP and βγMeATP, are not 
chemoattractants by themselves but they cause random migration (chemokinesis) and amplify 
chemotaxis induced by endogenous (IL-8) and bacterial exogenous chemoattractants (Boyden 
chamber assays), as well as by living bacteria (E. coli) (mouse peritonitis model). Secondly, 
P2X1-/- mice displayed impaired neutrophil recruitment in their peritoneum upon E. coli 
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injection. Thirdly, two-dimensional chemotaxis assays using collagen IV- or fibronectin-
coated microslides indicated that P2X1-/- neutrophils moved with diminished speed when 
placed in a gradient of a bacterial mimetic peptide. We also observed that static adhesion of 
P2X1-/- neutrophils to collagen IV was impaired. The reduced migration rates of these cells 
could therefore be partially explained by defective adhesion dynamics required for efficient 
cell movement. P2X1-/- neutrophils showed normal orientation in the gradient, migrated 
normally in Boyden chamber assays, and well polarized F-actin assembly still occurred when 
these cells were uniformly stimulated with W-peptide. These observations suggest that P2X1 
channels do not contribute to actin polymerization at the cell front and are not involved in 
gradient sensing. Accordingly, in Boyden chamber assays, pretreating human neutrophils with 
the P2X1 selective antagonist, NF449, did not affect the fMLP-induced chemotaxis 
(supplemental Fig. S1A).5 This is in sharp contrast with the role of P2Y2 receptors that, upon 
activation by ATP released from cell leading edge, are required for proper cell orientation in 
the gradient of W-peptide (6) and contribute to actin polymerization at the front (38). In 
agreement with these data, we noted that UTP, acting at P2Y2 receptors, was able to increase 
fMLP-induced chemotaxis when added together with fMLP in the bottom wells of the Boyden 
chamber, whereas αβMeATP could only promote chemotaxis when placed at the contact of 
the cells. Our findings thus emphasize differential roles for P2Y2 and P2X1 receptors in 
neutrophil migration. Since these two receptors are both activated by extracellular ATP (9), 
their differential effects could be related to different receptor localization (or relocalization) in 
membranes of migrating neutrophils and/or to the activation of distinct signaling pathways 
downstream from these receptors. The concentrations of ATP required to activate the two 
receptors in native cells may also differ. Furthermore, since P2X1 receptor-mediated 
responses can be potentiated by Gαq-coupled receptors (39), P2X1 and P2Y2 receptors could 
act cooperatively to promote chemotaxis. 
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The fact that P2X1-/- neutrophils move more slowly in a gradient of chemoattractant though 
polarizing normally indicates that structural front-rear polarisation is not sufficient to allow 
efficient and rapid cell movement. Conversely, it has been shown that cells with very weak 
morphological polarisation move more slowly but, similarly to P2X1-/- neutrophils, can 
chemotax with normal efficiency (40).  
Signaling polarity plays an important role in determining cell movement. Cells can indeed 
detect differences in the concentration of chemoattractant between points on their surface (41) 
and translate the extracellular gradient into an intracellular derivative, encoded by the 
signaling networks engaged by the chemoattractant. Localized accumulation of PI3Ps is a 
critical signal coordinating chemotaxis or movement and depends on PI3Kγ and SHIP-1 (31, 
40, 42). The study of Chen et al. proposed that ATP released from developing leading edges 
can act to control chemotaxis. However, the intracellular signals involved in this process 
remain undefined.  
In our study, we found that signals elicited upon P2X1 activation involved RhoA, Rho kinase 
and MLC phosphorylation. Several recent studies convincingly described a gradient of Rho 
activity along the axis of polarized neutrophils (low at the front) (43), driving myosin-based 
contraction at the rear (5, 44, 45). This backness pathway is mutually exclusive (in spatial 
terms), but partially dependent upon a frontness network, driven by the same chemoattractant 
and mediated via Gαi, PI3Kγ, Rac and F-actin (44). In agreement with normal morphological 
polarisation and F-actin assembly at the front of P2X1-/- neutrophils, we could not find any 
evidence for PI3Kγ, Rac or Cdc42 activation downstream from P2X1. Nevertheless, such 
frontness-backness interactions could, at least partially, explain how P2X1-mediated Rho 
activation at the rear would promote migration elicited by a chemoattractant. Moreover, in 
neutrophils, actomyosin-mediated contraction at the rear of the cell seems to be a major factor 
in both initiating movement and forcing the cell forward (45, 46). We thus propose that P2X1 
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activation by released ATP could trigger Rho-dependent amplification signals, facilitating 
membrane retraction at the receding end and possibly favouring migration-linked adhesion 
dynamics (47, 48). In agreement with this proposition, our time-lapse video microscopy 
analyses revealed more pronounced and persistent deformation of P2X1-/- neutrophils and 
delayed detachment of trailing edge appendages as compared to wild-type cells. This 
observation and the fact that the selective P2X1 agonist, αβMeATP, increases RhoA activity 
and promotes migration of wild-type neutrophils in a Rho kinase-dependent manner whereas 
it had no effect on P2X1-/- cells, strongly suggest that the P2X1-RhoA axis is required for 
efficient neutrophil movement, by favorizing tail retraction.   
The molecular link between P2X1 activation and RhoA remains unknown. RhoA is currently 
thought to be exclusively activated via Gα12/13 and Gαq (49) acting at guanine nucleotide 
exchange factors (GEFs) and GTPase-activating protein (GAPs) (50). There are at least 4 
RhoA GEFs that link Gα subunits to RhoA. Among them, Lsc has been shown to be required 
for normal RhoA activity, polarization, migration and adhesion of fMLP-stimulated 
neutrophils (51). Lsc-/- neutrophils showed inappropriate formation and retraction of 
supernumerary pseudopodia. They also exhibit enhanced chemokinesis, reduced directionality 
and adhesion but normal chemotaxis. Except for the fact that they both show normal gradient 
sensing, Lsc-/- and P2X1-/- neutrophils thus display very distinct phenotypes. Surprisingly, Lsc-/- 
neutrophils did not show any defect of tail retraction. It is thus unlikely that P2X1 would 
signal via Lsc.  
Interestingly, a recent work describes that a Ca2+/calmodulin(CaM)-dependent protein kinase 
(CaMK) increases Rac activity through its interaction with the GEF βPak-interacting 
exchange factor and GIT1 in hippocampal neurons (52). Noteworthy, in platelets, P2X1–
triggered Ca2+ influx causes CaM- and MLC kinase-dependent increase of MLC 
phosphorylation, leading to cell shape change (26). Although we cannot rule out the 
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possibility that P2X1 could also signal through Ca2+-dependent pathways independently of 
RhoA, it would be interesting to determine whether Ca2+- and CaMK-dependent mechanisms 
of RhoA activation exist in neutrophils. 
In conclusion, our study indicates that P2X1 ion channels contribute to the ATP-dependent 
control of neutrophil chemotaxis by activating signals that, in the presence of a 
chemoattractant, facilitate cell movement thereby enhancing chemotaxis. Further 
investigations are awaited to evaluate the importance of P2X1-dependent signals in vivo and to 
determine whether these receptors could constitute therapeutic targets for the treatment of 
inflammatory diseases.  
To our knowledge, this is the first evidence that P2X1 ion channels contribute to cell 
migration. Beside the presently described role in neutrophils, it is possible that similar 
mechanisms apply to other P2X1-expressing cell types. It is striking to note that P2X1 ion 
channels are abundantly expressed on vascular smooth muscle cells (35, 53, 54) and on 
microglia (55) and might therefore contribute to various disorders related to migration of 
these cells that include development of restenosis, diabetic microvascular disease, chronic 
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FIGURE 1. Human neutrophils express functional P2X1 channels. A, Western blotting 
detection of P2X1 proteins in neutrophil or platelet protein extracts. B, Whole cell currents 
recorded at -70mV holding potential. The average cell capacitance of human peripheral 
neutrophils was 2.1 ± 1.0 pF (mean ± SD). Representative traces of inward currents induced 
by optimal concentrations of αβMeATP (10µM) and βγMeATP (10µM). The histograms 
depict current density. Averaged data are from at least three independent experiments with 
neutrophils of different individuals. 
 
FIGURE 2. αβMeATP induces random migration of human peripheral neutrophils and 
enhances chemotaxis. Boyden chamber assays on human peripheral neutrophils. A, 
αβMeATP (10 µM) or HBSS (neutrophil resuspension buffer), B, IL-8 (100 ng/ml), or C-E, 
fMLP (100nM). D, αβMeATP (10 µM) or E, UTP (10 µM) were combined or not with fMLP 
(100 nM) and placed in the bottom wells of the chamber, as indicated below the solid bars. 
The “+” or “-” symbols above the solid bars indicate that neutrophils were pre-stimulated or 
not with the indicated agonists (αβMeATP in A-D, or UTP in E) for 1 min prior to addition to 
the upper wells of the chamber. Averaged data are from at least three independent 
experiments with neutrophils of different individuals. A-C, *p<0.05, **p<0.01, ***p<0.001 vs 
absence of αβMeATP in the upper wells. E, *p<0.05 vs absence of UTP. 
 
FIGURE 3. Role of RhoA-Rho kinase pathway in αβMeATP-triggered migration of human 
neutrophils. A-B, RhoGTPase activities assessed by GST-pull down assays. Human 
neutrophils were stimulated with αβMeATP (10µM) for the indicated times. Immunoblots 
depicting GST-bound and total GTPase levels are shown. A, A representative immunoblot of 
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GST-bound and total RhoA and levels of GST-bound RhoA normalized to the signal detected 
in the absence of αβMeATP are shown. B, Representative immunoblots of GST-bound and 
total Rac1, Rac2 and Cdc42. C, Representative immunoblot of phosphorylated (P-MLC) and 
total myosin light chain (MLC) in neutrophils stimulated with αβMeATP (10µM) for the 
indicated times. Bottom panel, results of band quantification. Levels of P-MLC were 
normalized to the signal detected in the absence of αβMeATP. D, Boyden chamber assays. 
αβMeATP-treated neutrophils were preincubated or not with the Rho kinase inhibitors, 
Y27632 (5µM) or H1152 (1µM) for 15 min. αβMeATP (10µM) was added in the bottom 
wells. Cell migration in the presence of HBSS is also shown (control). E, fMLP (100 nM) was 
placed in the bottom wells of the Boyden chamber. Neutrophils preincubated or not with the 
Rho kinase inhibitor Y27632 (5 µM) were placed in the upper wells in the presence or 
absence of αβMeATP (10 µM), as indicated. Data represent the means ± SD of at least three 
independent experiments with neutrophils of different individuals. A, *p<0.05 vs control. C, 
**p<0.01 vs control. D, **p<0.01 vs HBSS control, #p<0.05 vs αβMeATP. E, ***p<0.001 vs 
fMLP alone (control), ###p<0.001 vs αβMeATP.  
 
FIGURE 4. Characterization of P2X1-/- neutrophils. Whole cell currents recorded at -70mV 
holding potential. The average cell capacitance of mouse peritoneal neutrophils was 1.7 ± 0.3 
pF (mean ± SD). Representative traces of αβMeATP (10µM) and βγMeATP (10µM) induced 
inward currents in WT and P2X1-/- peritoneal neutrophils. 
 
FIGURE 5. Chemotaxis and RhoA signaling in wild-type and P2X1-/- neutrophils. A-B, 
Boyden chamber assays. A, W-peptide (100 nM) was placed in the bottom wells of the 
chamber. Wild-type (WT) and P2X1-/- peritoneal neutrophils were pretreated or not (control) 
with αβMeATP (10µM) for 1 min prior being placed in the upper wells. B, WT neutrophils 
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were preincubated or not with the Rho kinase inhibitors H1152 (1 µM) or Y27632 (5 µM) 
before pretreatment with αβMeATP, as indicated. Migrating neutrophils were counted after 1 
hour. Averaged data are from at least three independent experiments with neutrophil pools 
from three mice. A, *p<0.05 vs absence of αβMeATP (control). B, **p<0.01 vs absence of 
αβMeATP (control), ###p<0.001 vs absence of inhibitors. C, RhoA GTPase activity was 
assessed in WT and P2X1-/- neutrophils stimulated with αβMeATP (10µM) for the indicated 
times. Numbers below the immunoblots represent the fold-increase of RhoA activity 
normalized to the signal detected in the absence of αβMeATP. Data are representative of two 
independent experiments with neutrophil pools from 8 animals. 
 
FIGURE 6. Impaired static adhesion, diminished speed and increased time to trailing edge 
retraction for P2X1-/- neutrophils. A-C, Study of WT and P2X1-/- neutrophil two-dimensional 
migration using collagen IV-coated Ibidi chemotaxis microslides. A, Migration speed. B, 
Representative image captured at 60 min showing several P2X1-/- neutrophils with a persistent 
trailing edge (white arrows). C, Averaged circularity ratio of cells during the time course of 
three independent experiments. Between 40 and 100 cells were assigned scores. *p<0.05, 
**p<0.01. D, Static cell adhesion assay. Peritoneal neutrophils were placed onto collagen IV-
coated wells for 15 min and the percentage of adherent cells was determined. Averaged data 
are from three independent experiments with neutrophil pools from two animals. *p<0.05 vs 
WT. 
 
FIGURE 7. Normal F-actin polymerisation in P2X1-/- neutrophils uniformly stimulated with 
W-peptide. Confocal images of murine peritoneal neutrophils adhered to collagen IV and 
incubated with 100 nM W-peptide for the indicated times before labeling with Alexa 488-




FIGURE 8. P2X1 promotes neutrophil recruitment in vivo in a model of E. coli-induced 
peritonitis. A, WT mice injected intraperitoneally with either PBS (vehicle) or E.coli. These 
mice were injected intraperitoneally with αβMeATP or vehicle (control) prior to and after E. 
coli injection. First treatment was administered 15 min before E.coli/vehicle; second and third 
treatments were given after 1 and 2 hours, respectively. Mice were sacrificed after 3 hours. 
Neutrophils were counted in the peritoneal lavages. B, WT and P2X1-/- mice injected 
intraperitoneally with PBS (vehicle) or E.coli. A-B, Averaged data are from three independent 
experiments performed with groups of four to six mice. A, *p<0.05 vs control; #p<0,05 vs 
vehicle, ###p<0,001 vs vehicle. B, *p<0.05 WT E.coli vs P2X1-/- E.coli; #p<0,05 vs vehicle, 
###p<0,001 vs vehicle 
 
 
 
 
 
 








